Berman Capital Advisors’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | $71K | Buy |
936
+348
| +59% | +$26.4K | 0.01% | 546 |
|
|
2021
Q2 | $48K | Buy |
588
+183
| +45% | +$14.9K | 0.01% | 595 |
|
|
2021
Q1 | $30K | Sell |
405
-176
| -30% | -$13K | 0.01% | 655 |
|
|
2020
Q4 | $50K | Buy |
581
+498
| +600% | +$42.9K | 0.01% | 406 |
|
|
2020
Q3 | $6K | Sell |
83
-95
| -53% | -$6.87K | ﹤0.01% | 955 |
|
|
2020
Q2 | $21K | Buy |
178
+85
| +91% | +$10K | 0.01% | 528 |
|
|
2020
Q1 | $7K | Buy |
+93
| New | +$7K | ﹤0.01% | 759 |
|
|
2019
Q4 | – | Sell |
-98
| Closed | -$6K | – | 1464 |
|
|
2019
Q3 | $6K | Sell |
98
-144
| -60% | -$8.82K | ﹤0.01% | 878 |
|
|
2019
Q2 | $20K | Sell |
242
-175
| -42% | -$14.5K | 0.01% | 511 |
|
|
2019
Q1 | $36K | Buy |
417
+151
| +57% | +$13K | 0.01% | 327 |
|
|
2018
Q4 | $22K | Buy |
+266
| New | +$22K | 0.01% | 367 |
|